Catalytic and reactive polypeptides and methods for their preparation and use

• US 5,215,889 A
• Filed: 09/08/1989
• Issued: 06/01/1993
• Est. Priority Date: 11/18/1988
• Status: Expired due to Term

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Schultz, Peter
• Primary Examiner(s): Patterson, Jr., Charles L.
• Application Number:
  US07/404,920
• Time in Patent Office: 1,362 Days
• Field of Search: 435/183, 435/195, 435/196, 435/189, 435/188.5, 435/41, 530/387, 530/388, 530/389, 530/390
• US Class Current: 435/41
• CPC Class Codes: A61K 47/68 the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
• CPC Class Codes: A61K 47/6835 the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: C12N 15/10 Processes for the isolation, preparation or purification of DNA or RNA chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34
• CPC Class Codes: C12N 9/0002 Antibodies with enzymatic activity, e.g. abzymes
• CPC Class Codes: C12N 9/86 acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)

Abstract

Catalytic and reactive polypeptides include a binding site specific for a reactant or reactive intermediate involved in a chemical reaction of interest. The polypeptides further include at least one active functionality proximate the bi

This invention was made with Government support under Grant Contract No. AI-24695 awarded by the Department of Health and Human Services, under Grant Contract No. N 00014-87-K-0256, awarded by the Office of Naval Research. The Government has certain rights in this invention, under Grant Contract CHE 8822412 awarded by the National Science Foundation, and under Grant Subcontract C87-101226 awarded by the Department of Energy.

Claims

1. A polypeptide capable of promoting a chemical reaction involving the conversion of one or more reactants to one or more products, said polypeptide having a binding site specific for at last one reactant or reaction intermediate, wherein the polypeptide is other than a naturally occurring enzyme and includes at least one active functionality covalently attached to the polypeptide proximate the binding site, which functionality is capable of chemically participating in the chemical reaction or catalytically enhancing the chemical reaction rate, wherein the functionality is either a moiety covalently attached to an amino acid side chain proximate the binding site or an amino acid side chain other than a naturally occurring amino acid side chain and wherein the polypeptide is an antibody or antibody fragment.

2. A polypeptide as in claim 1, wherein the distance between the active functionality and the binding site is less than about 20 Å

.

3. A polypeptide as in claim 1, wherein the active functionality is capable of catalytically enhancing the reaction rate and is selected from the group consisting of acids, bases, enzyme cofactors, metal complexes, photoactive molecules, nucleophiles, electrophiles, and redox active molecules.

4. A polypeptide as in claim 1, wherein the active functionality is capable of chemically participating in the chemical reaction and is selected from the group consisting of alkylating agents, oxidizing agents, reducing agents, hydrolytic agents, and photoactive agents.

5. A polypeptide having a binding site and an active functionality covalently attached to a side chain of an amino acid proximate the binding site, wherein the binding site is capable of complexing a reactant or reaction intermediate in a chemical reaction and the active functionality is capable of enhancing the rate of a chemical reaction, and wherein the polypeptide is an antibody or an antibody fragment.

6. A polypeptide as in claim 5, wherein the active functionality is capable of catalytically enhancing the reaction rate and is selected from the group consisting of acids, bases, enzyme cofactors, metal complexes, photoactive molecules, nucleophiles, electrophiles, and redox active molecules.

7. A polypeptide as in claim 6, wherein the active functionality is an enzyme cofactor or derivative thereof selected from the group consisting of flavins, porphyrins, thiamine, pyridoxamine, nicotinamide, biotin, and folates.

8. A polypeptide as in claim 6, wherein the active functionality is a metal complex selected from the group consisting of chelated Lewis acids, redox active metal complexes, photoactive metal complexes, oxygen activating metal complexes, and radioactive metal complexes.

9. A polypeptide as in claim 5, wherein the active functionality is capable of chemically participating in the chemical reaction and is selected from the group consisting of alkylating agents, oxidizing agents, reducing agents, hydrolytic agents, photosensitizers, electrophiles, nucleophiles, acids, and bases.

10. A polypeptide as in claim 5, which is a modification of the F(ab) or Fv fragment of an antibody.

11. A polypeptide as in claim 5, wherein the active functionality is covalently attached to a side chain of an amino acid other than a naturally occurring amino acid.

12. A method for enhancing the rate of a chemical reaction involving the conversion of one or more reactants to one or more products, said method comprising exposing a reaction mixture including said reactant(s) to a polypeptide selected from the group consisting of antibodies and antibody fragments and having a binding site capable of forming a complex with said reactant(s) or a reaction intermediate including said reactant(s), wherein an active functionality is a side chain of a non-natural amino acid proximate the binding site or is a moiety covalently attached to a side chain of an amino acid proximate the binding site, said active functionality being capable of promoting the conversion of reactant(s) to product(s).

13. A method as in claim 12, wherein the active functionality is a catalytic functionality selected from the group consisting of acids, bases, enzyme cofactors, metal complexes, photoactive molecules, nucleophiles, electrophiles, and redox active molecules.

14. A method as in claim 13, wherein the catalytic functionality is an enzyme cofactor or derivative thereof selected from the group consisting of flavine, porphyrins, thiamine, pyridoxamine, nicotinamide, biotin, and folates.

15. A method as in claim 13, wherein the catalytic functionality is a metal complex selected from the group consisting of chelated Lewis acids, redox active metal complexes, photoactive metal complexes, oxygen activating metal complexes, and radioactive metal complexes.

16. A method as in claim 12, wherein the active functionality is a reactive functionality selected from the group consisting of alkylating agents, oxidizing agents, reducing agents, hydrolytic agents, photosensitizers, electrophiles, nucleophiles, acids, and bases.

17. A method as in claim 12, wherein the antibody has been prepared against a hapten which is a reactant, a reactant analog, a transition state analog, or a multisubstrate analog.

18. A method as in claim 12, wherein the reaction is ester hydrolysis and the active functionality is an imidazole derivative.

19. A method as in claim 12, wherein the reaction is thiolysis and the active functionality is alkyl mercaptan.